文献速递妇科生殖医学

在线调查中自报子宫内膜异位症和子宫腺肌病数据的可靠性:ComPaRe-子宫内膜异位症电子队列研究结果

Reliability of self-reported endometriosis and adenomyosis data in online surveys: results from the ComPaRe-Endometriosis e-cohort.
PubMed 文献 · Hum Reprod · 2025-01-01

在ComPaRe-子宫内膜异位症法国电子队列中,215名参与者提供了医疗报告;自报诊断、诊断年龄和分期的可靠性强至极好,子宫内膜异位症宏观表型的可靠性一般至中等。

要点

  • 自报子宫内膜异位症和子宫腺肌病诊断正确率分别为95.9%和90.3%。
  • 自报诊断年龄可靠性极好:子宫内膜异位症ICC=0.96,子宫腺肌病ICC=0.91。
  • 子宫内膜异位症宏观表型可靠性一般至中等:子宫内膜瘤K=0.62-0.74,深部子宫内膜异位症K=0.40-0.61,浅表腹膜型K=0.35-0.43。

核心结论

  • 在本样本中,自报诊断、诊断年龄和分期的可靠性强至极好,子宫内膜异位症宏观表型的可靠性一般至中等。

研究设计与样本

  • 在ComPaRe-子宫内膜异位症法国电子队列(2018年启动)内开展专项研究,共215名参与者发送了医疗报告。
  • 比较基线自报问卷数据与同期医疗报告数据,采用描述性统计、组内相关系数(ICC)、Cohen's Kappa和加权Kappa评估可靠性。

主要发现

  • 参与者平均年龄33.8岁(SD=7.0),52.1%仅报告子宫内膜异位症,8.4%仅报告子宫腺肌病,39.5%报告两者均有。
  • 子宫内膜异位症和子宫腺肌病诊断正确报告率分别为95.9%和90.3%。
  • 自报诊断年龄可靠性极好:子宫内膜异位症ICC=0.96,子宫腺肌病ICC=0.91。
  • 自报疾病分期一致性为中等至几乎完全一致(κw=0.86-0.78),可靠性极好(ICC=0.91-0.94)。
  • 自报子宫内膜异位症宏观表型一致性:子宫内膜瘤中等(K=0.62-0.74),深部子宫内膜异位症中等至中等(K=0.40-0.61),浅表腹膜型一般至中等(K=0.35-0.43)。

关键数值与推荐

  • 自报子宫内膜异位症诊断正确率95.9%,子宫腺肌病诊断正确率90.3%。
  • 自报诊断年龄ICC:子宫内膜异位症0.96,子宫腺肌病0.91。
  • 自报疾病分期κw=0.86-0.78,ICC=0.91-0.94。
  • 自报宏观表型Kappa:子宫内膜瘤0.62-0.74,深部子宫内膜异位症0.40-0.61,浅表腹膜型0.35-0.43。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 最积极的参与者可能在参与自身照护方面具有特定特征,这构成了研究结果外推性的局限。
  • 医疗报告中对疾病宏观表型的描述存在显著异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How reliable are self-reported endometriosis or adenomyosis data compared with medical reports in online patient surveys? SUMMARY ANSWER: In our sample, reliability was strong to excellent for diagnosis, age at diagnosis, and stage at diagnosis, while reliability for macro-phenotype of endometriosis ranged from fair to substantial. WHAT IS KNOWN ALREADY: Many online surveys rely on self-reported endometriosis data. Previous research has shown validation rates ranging from 72% to 95% for self-reported endometriosis diagnosis in population cohorts, but this rate is unknown in the context of online surveys among patient populations or patient e-cohorts. STUDY DESIGN, SIZE, DURATION: We conducted a specific study within ComPaRe-Endometriosis, a French e-cohort launched in 2018 and following up several thousands of women with endometriosis and/or adenomyosis. Within this study, a total of 215 participants sent their medical reports. We compared participants' self-reported diagnosis and disease characteristics, as collected in self-reported questionnaires at baseline in the ComPaRe-Endometriosis cohort, with data from contemporaneous medical reports. PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants were asked to send their medical reports mentioning diagnosis and its date, and type(s) and stage of endometriosis. We assessed the reliability between baseline self-reported data and medical report data using descriptive statistics, intraclass correlation coefficient (ICC), Cohen's Kappa, and weighted Kappa. MAIN RESULTS AND THE ROLE OF CHANCE: The study included 215 participants with a mean age of 33.8 years (SD = 7.0). Over half (52.1%) reported endometriosis alone, 8.4% adenomyosis alone, and 39.5% reported both diseases. Endometriosis and adenomyosis diagnoses were correctly reported among 95.9% and 90.3% of participants, respectively. Self-reported age at diagnosis showed excellent reliability with ICC = 0.96 for endometriosis and ICC = 0.91 for adenomyosis. Regarding self-reported disease stage, substantial-to-almost perfect agreement (κw = 0.86-0.78) and excellent reliability (ICC = 0.91-0.94) were observed. For self-reported macro-phenotype of endometriosis, agreement varied: substantial for endometrioma (K = 0.62-0.74), moderate-to-substantial for deep endometriosis (K = 0.40-0.61), and fair-to-moderate for superficial peritoneal endometriosis (K = 0.35-0.43). LIMITATIONS, REASONS FOR CAUTION: The most motivated participants may have a particular profile in terms of involvement in their care, which constitutes a limitation to the generalizability of the findings. WIDER IMPLICATIONS OF THE FINDINGS: Several studies assessed the reliability of self-reported endometriosis data in population cohorts and found validation rates ranging from 72% to 95% with medical reports. This figure could vary greatly depending on several criteria (study population, clarity of the question about diagnosis, tool used to confirm diagnosis…). In this work, we found a striking heterogeneity in the way macro-phenotype of disease was described in medical reports. Since many studies rely on self-reported data, this work underscores the importance of harmonizing the report of diagnosis and endometriosis/adenomyosis characteristics in medical reports in order to ease continuity of care and ensure high-quality research on these conditions. STUDY FUNDING/COMPETING INTEREST(S): The ComPaRe cohort was supported by the Assistance Publique-Hôpitaux de Paris (APHP) and the Université Paris Cité. ComPaRe-Endometriosis was funded through grants from the Fondation de France (#00132975/WB-2022-44780) and the Agence Nationale de la Recherche (#ANR-22-CE36-0016-01) and received donations from patient societies and initiatives (EndoMind, EndoFrance, EndoAction, Les Joyeux Boulomanes Farlédois, La Belle et L'endo, Les Chroniques Endométriques). S.G. was supported by a PhD scholarship from the French Ministry of Research and a grant from the Crédit Agricole Ile-de-France Mécénat. Z.B. was supported by the French National Association for Research and Technology (ANRT) and Lyv Healthcare during their PhD. The funders had no role in the design, interpretation, or decision to publish the study. The other authors report no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Gouesbet S, du Cheyron J, Amazouz H, et al. Reliability of self-reported endometriosis and adenomyosis data in online surveys: results from the ComPaRe-Endometriosis e-cohort. Hum Reprod. 2025. PMID: 40882977. doi:10.1093/humrep/deaf160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。